About us
Our role
Established in 2022 by the World Economic Forum, the US National Academy of Medicine, and the Coalition for Epidemic Preparedness Innovations (CEPI), RVMC has evolved into an independent initiative supporting sustainable regional vaccine manufacturing across Africa, ASEAN, and Latin America and the Caribbean.
Our role is to help make regional vaccine manufacturing ecosystems work more effectively. Bringing an independent, system-wide perspective, we provide evidence and strategic advice to support informed decisions, identify regional priorities, and connect the expertise and resources needed to advance sustainable manufacturing. We also strengthen cooperation between regions, helping them learn from one another, share experiences and identify opportunities for joint action.
Who we are
RVMC Secretariat
Hosted by CEPI, the Secretariat coordinates RVMC's day-to-day work, providing analysis, strategic advice, and support to partners.
Dr. Frederik Kristensen
Managing Director
Dr. Michael Lusiola
Director
Luigi Bonfatti
Executive Advisor
Emmanuelle Naud
Senior Project Manager
Vishal Gajwani
Senior Vaccine Market Advisor
Holly Wingfield
External Engagement and Governance Manager
Ariane de Jesus Lopes de Abreu
Regional Technical Lead - LAC
Jessabelle Basa
Regional Technical Lead - ASEAN
Daniela Eriksen
RVMC Coordinator
Executive Committee
The Executive Committee oversees RVMC's strategy, priorities and activities, providing guidance on how best to achieve our objectives.
Dr. Richard Hatchett
CEO, Coalition for Epidemic Preparedness Innovations
Dr. Victor Dzau
President, US National Academy of Medicine
Dr. Shyam Bishen
Head, Centre for Health and Healthcare, World Economic Forum
Dr. Monique Vledder
Global Director of the Health, Nutrition and Population Unit, World Bank Group
H.E Dr. Jean Kaseya
Director-General, Africa Centres for Disease Control and Prevention
Dr. Jarbas Barbosa
Director, Pan American Health Organization
Dr. Nakorn Premsri
Director, Thailand National Vaccine Institute
Strategic Advisory Board (SAB)
The Strategic Advisory Board brings together leading institutions working on regional vaccine manufacturing to share perspectives, discuss key challenges and opportunities, and help shape collective efforts to advance our shared vision.
Anne Marie Mbengue Seye
Managing Partner - Global Health, Performances Group
Minister Bandar Ibrahim Alkhorayef
Ministry of Industry and Mineral Resources, Kingdom of Saudi Arabia
Minister Budi Gunadi Sadikin
Ministry of Health, Indonesia
Catherine Russell
Executive Director, UNICEF
Daren Tang Heng Shim
Director General, World Intellectual Property Organization
Dr. David Robinson
Deputy Director, Vaccine Development & Surveillance, The Gates Foundation
Dr. David Reddy
Director General, IFPMA
Farrah Losper
Chair, AVMI
Secretary Fernanda de Negri
Science, Technology, and Innovation in Health, Ministry of Health of Brazil
Dr. Hanan Balkhy
Regional Director, WHO-EMRO
Dr. Jerome Kim
Director General, IVI
Dr. John-Arne Røttingen
CEO, Wellcome
Martin Seychell
Deputy Director General, INTPA, European Commission
Minister Muhammad Ali Pate
Ministry of Health, Nigeria
Dr. Ngozi Okonjo-Iweala
Director General, World Trade Organization
Minister Ong Ye Kung
Ministry of Health, Singapore
Rajinder Suri
CEO, DCVMN
Dr. Sania Nishtar
CEO, Gavi
Who we work with
Regional Bodies
We support regional bodies with the political mandate to enhance vaccine manufacturing capabilities, aligning with their strategic goals.
National Governments
We advise national governments on their vaccine manufacturing plans, promoting coordination with like-minded countries and regional strategies.
Industry
We collaborate with industry partners to develop a comprehensive understanding of the landscape, identifying opportunities that align with regional strategies.
Funders
We provide guidance to funders on viable projects that align with regional vaccine manufacturing strategies.
International Organizations/Agencies
We work with international organizations to build consensus on the global vision for regionalized manufacturing and identify opportunities for collaborative partnerships.